 Kartik Balachandran
Concepts (187)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Valve | 15 | 2024 | 130 | 4.810 |
Why?
| | Calcinosis | 4 | 2024 | 53 | 2.420 |
Why?
| | Aortic Valve Stenosis | 4 | 2024 | 79 | 2.010 |
Why?
| | Heart Valves | 6 | 2020 | 31 | 1.970 |
Why?
| | Tissue Engineering | 6 | 2024 | 74 | 1.720 |
Why?
| | Lab-On-A-Chip Devices | 2 | 2024 | 10 | 1.720 |
Why?
| | Cell Culture Techniques | 3 | 2025 | 99 | 1.550 |
Why?
| | Stress, Mechanical | 12 | 2022 | 95 | 1.440 |
Why?
| | Cells, Cultured | 15 | 2025 | 1569 | 1.400 |
Why?
| | Extracellular Matrix | 6 | 2024 | 116 | 1.320 |
Why?
| | Heart Valve Diseases | 4 | 2017 | 55 | 1.280 |
Why?
| | Swine | 16 | 2024 | 440 | 1.210 |
Why?
| | Tissue Scaffolds | 3 | 2020 | 40 | 1.160 |
Why?
| | Biocompatible Materials | 3 | 2025 | 67 | 1.060 |
Why?
| | Dimethylpolysiloxanes | 2 | 2025 | 3 | 1.050 |
Why?
| | Hydrogels | 3 | 2024 | 26 | 0.990 |
Why?
| | Serotonin | 3 | 2017 | 144 | 0.880 |
Why?
| | Nasal Mucosa | 1 | 2024 | 19 | 0.860 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 2 | 2020 | 7 | 0.840 |
Why?
| | Cholesterol | 1 | 2024 | 161 | 0.820 |
Why?
| | Epithelial Cells | 1 | 2024 | 218 | 0.770 |
Why?
| | Animals | 24 | 2024 | 13526 | 0.730 |
Why?
| | Cell Nucleus | 3 | 2020 | 187 | 0.710 |
Why?
| | Collagen | 4 | 2017 | 215 | 0.710 |
Why?
| | Renin-Angiotensin System | 1 | 2021 | 58 | 0.690 |
Why?
| | Cell Differentiation | 5 | 2024 | 681 | 0.670 |
Why?
| | Angiotensin II | 2 | 2021 | 161 | 0.640 |
Why?
| | Cytoskeleton | 2 | 2017 | 39 | 0.630 |
Why?
| | Nanofibers | 2 | 2016 | 8 | 0.610 |
Why?
| | Muscle Contraction | 2 | 2016 | 114 | 0.590 |
Why?
| | Laminin | 1 | 2017 | 20 | 0.530 |
Why?
| | Osteoblasts | 1 | 2020 | 480 | 0.520 |
Why?
| | Proteoglycans | 1 | 2017 | 86 | 0.520 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2017 | 102 | 0.510 |
Why?
| | Aquaporin 4 | 1 | 2016 | 8 | 0.500 |
Why?
| | Cell Shape | 1 | 2016 | 21 | 0.500 |
Why?
| | Acetazolamide | 1 | 2016 | 16 | 0.500 |
Why?
| | Edema | 1 | 2016 | 64 | 0.480 |
Why?
| | Blood Pressure | 3 | 2017 | 518 | 0.460 |
Why?
| | Disease Progression | 3 | 2024 | 880 | 0.440 |
Why?
| | Energy Metabolism | 1 | 2016 | 324 | 0.420 |
Why?
| | Hypertension | 2 | 2017 | 554 | 0.410 |
Why?
| | Regeneration | 2 | 2011 | 83 | 0.410 |
Why?
| | Extracellular Matrix Proteins | 2 | 2019 | 69 | 0.390 |
Why?
| | Cell Proliferation | 5 | 2017 | 1031 | 0.380 |
Why?
| | Mechanotransduction, Cellular | 2 | 2017 | 42 | 0.370 |
Why?
| | Endothelial Cells | 3 | 2024 | 289 | 0.360 |
Why?
| | Endothelium | 1 | 2011 | 38 | 0.360 |
Why?
| | Morphogenesis | 1 | 2011 | 17 | 0.360 |
Why?
| | Receptors, Serotonin, 5-HT2 | 1 | 2011 | 1 | 0.360 |
Why?
| | Pressoreceptors | 1 | 2011 | 8 | 0.360 |
Why?
| | Mesoderm | 1 | 2011 | 30 | 0.350 |
Why?
| | Receptors, Serotonin | 1 | 2011 | 25 | 0.350 |
Why?
| | Disease Models, Animal | 4 | 2020 | 1517 | 0.310 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2010 | 67 | 0.310 |
Why?
| | Receptor, Angiotensin, Type 1 | 2 | 2021 | 56 | 0.300 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 1003 | 0.280 |
Why?
| | Models, Biological | 4 | 2024 | 737 | 0.280 |
Why?
| | Blood-Brain Barrier | 2 | 2018 | 51 | 0.270 |
Why?
| | Phenotype | 3 | 2017 | 803 | 0.260 |
Why?
| | Shear Strength | 3 | 2016 | 11 | 0.260 |
Why?
| | Glycosaminoglycans | 2 | 2020 | 19 | 0.250 |
Why?
| | Humans | 10 | 2025 | 53230 | 0.250 |
Why?
| | Astrocytes | 2 | 2019 | 139 | 0.240 |
Why?
| | Cell Survival | 3 | 2017 | 600 | 0.240 |
Why?
| | Tissue Culture Techniques | 3 | 2011 | 42 | 0.240 |
Why?
| | Materials Testing | 1 | 2025 | 55 | 0.230 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 43 | 0.230 |
Why?
| | Bioreactors | 2 | 2019 | 10 | 0.220 |
Why?
| | Air | 1 | 2024 | 22 | 0.220 |
Why?
| | Myocytes, Cardiac | 1 | 2025 | 147 | 0.210 |
Why?
| | Anisotropy | 2 | 2016 | 62 | 0.210 |
Why?
| | Coculture Techniques | 1 | 2024 | 146 | 0.210 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 1925 | 0.200 |
Why?
| | Cell Cycle | 1 | 2024 | 237 | 0.200 |
Why?
| | Homeostasis | 1 | 2024 | 209 | 0.200 |
Why?
| | Endothelium, Vascular | 2 | 2018 | 262 | 0.190 |
Why?
| | Angiotensin I | 1 | 2021 | 14 | 0.180 |
Why?
| | Tetrahydroisoquinolines | 1 | 2021 | 10 | 0.180 |
Why?
| | Losartan | 1 | 2021 | 27 | 0.180 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2021 | 27 | 0.180 |
Why?
| | Fluorescent Antibody Technique | 1 | 2021 | 109 | 0.180 |
Why?
| | Models, Cardiovascular | 3 | 2011 | 22 | 0.170 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 73 | 0.170 |
Why?
| | Myofibroblasts | 1 | 2021 | 50 | 0.170 |
Why?
| | Tight Junctions | 2 | 2018 | 28 | 0.170 |
Why?
| | Gelatin | 1 | 2020 | 22 | 0.170 |
Why?
| | Time Factors | 3 | 2020 | 2991 | 0.160 |
Why?
| | Early Diagnosis | 1 | 2020 | 84 | 0.160 |
Why?
| | Primary Cell Culture | 1 | 2020 | 62 | 0.160 |
Why?
| | Rats | 4 | 2019 | 3162 | 0.150 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2016 | 43 | 0.150 |
Why?
| | Signal Transduction | 3 | 2011 | 1748 | 0.150 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 333 | 0.150 |
Why?
| | Periodicity | 2 | 2010 | 25 | 0.140 |
Why?
| | Feasibility Studies | 1 | 2020 | 411 | 0.140 |
Why?
| | Capillary Permeability | 1 | 2018 | 29 | 0.140 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 934 | 0.140 |
Why?
| | Cell Separation | 1 | 2017 | 76 | 0.130 |
Why?
| | Receptor, Serotonin, 5-HT2B | 1 | 2017 | 1 | 0.130 |
Why?
| | Fibrillar Collagens | 1 | 2017 | 2 | 0.130 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2017 | 12 | 0.130 |
Why?
| | Sus scrofa | 1 | 2017 | 38 | 0.130 |
Why?
| | Drug Combinations | 1 | 2017 | 138 | 0.130 |
Why?
| | Fetal Blood | 1 | 2017 | 79 | 0.130 |
Why?
| | Collagen Type I | 1 | 2017 | 83 | 0.130 |
Why?
| | Cell Size | 1 | 2016 | 45 | 0.130 |
Why?
| | Brain Concussion | 1 | 2018 | 111 | 0.120 |
Why?
| | Fibrosis | 1 | 2017 | 198 | 0.120 |
Why?
| | Mitochondria | 1 | 2020 | 446 | 0.120 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2016 | 96 | 0.120 |
Why?
| | Water | 1 | 2016 | 87 | 0.120 |
Why?
| | Stroke Volume | 1 | 2017 | 150 | 0.120 |
Why?
| | Ventricular Function, Left | 1 | 2017 | 178 | 0.120 |
Why?
| | Biophysical Phenomena | 1 | 2015 | 15 | 0.110 |
Why?
| | Apoptosis | 2 | 2010 | 1139 | 0.110 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2014 | 50 | 0.100 |
Why?
| | Polymers | 1 | 2014 | 51 | 0.100 |
Why?
| | Osteogenesis | 1 | 2016 | 374 | 0.100 |
Why?
| | Pulsatile Flow | 2 | 2010 | 18 | 0.100 |
Why?
| | Phantoms, Imaging | 1 | 2014 | 112 | 0.100 |
Why?
| | Up-Regulation | 2 | 2011 | 456 | 0.090 |
Why?
| | Ketanserin | 1 | 2011 | 9 | 0.090 |
Why?
| | Serotonin 5-HT2 Receptor Antagonists | 1 | 2011 | 9 | 0.090 |
Why?
| | Sheep | 1 | 2011 | 99 | 0.090 |
Why?
| | Sampling Studies | 1 | 2011 | 38 | 0.090 |
Why?
| | Fluoxetine | 1 | 2011 | 42 | 0.090 |
Why?
| | Myocardial Contraction | 1 | 2011 | 109 | 0.090 |
Why?
| | Urea | 1 | 2011 | 80 | 0.090 |
Why?
| | Myoblasts, Cardiac | 1 | 2011 | 3 | 0.090 |
Why?
| | Actins | 1 | 2011 | 114 | 0.090 |
Why?
| | Antigens, Differentiation | 1 | 2011 | 16 | 0.090 |
Why?
| | Proteins | 1 | 2014 | 351 | 0.080 |
Why?
| | Reference Values | 1 | 2011 | 311 | 0.080 |
Why?
| | Pressure | 1 | 2011 | 102 | 0.080 |
Why?
| | Chordae Tendineae | 1 | 2010 | 4 | 0.080 |
Why?
| | Random Allocation | 1 | 2011 | 284 | 0.080 |
Why?
| | Tensile Strength | 1 | 2010 | 31 | 0.080 |
Why?
| | Male | 2 | 2020 | 27435 | 0.080 |
Why?
| | Culture Media | 1 | 2010 | 97 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 579 | 0.080 |
Why?
| | Blotting, Western | 1 | 2011 | 587 | 0.080 |
Why?
| | Mitral Valve | 1 | 2010 | 57 | 0.080 |
Why?
| | Alkaline Phosphatase | 1 | 2010 | 92 | 0.080 |
Why?
| | Stress, Physiological | 1 | 2011 | 184 | 0.080 |
Why?
| | Regional Blood Flow | 1 | 2009 | 112 | 0.080 |
Why?
| | Serotonin Agents | 1 | 2009 | 14 | 0.080 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2009 | 1 | 0.070 |
Why?
| | Cathepsins | 1 | 2009 | 6 | 0.070 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2009 | 31 | 0.070 |
Why?
| | Organ Culture Techniques | 1 | 2009 | 44 | 0.070 |
Why?
| | Bone Morphogenetic Protein 4 | 1 | 2008 | 8 | 0.070 |
Why?
| | Fibroblasts | 1 | 2011 | 363 | 0.070 |
Why?
| | Indoles | 1 | 2011 | 280 | 0.070 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2008 | 59 | 0.070 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2008 | 38 | 0.070 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2008 | 61 | 0.070 |
Why?
| | Calcium | 1 | 2010 | 373 | 0.070 |
Why?
| | Nitric Oxide | 1 | 2009 | 233 | 0.070 |
Why?
| | Physical Stimulation | 1 | 2006 | 30 | 0.060 |
Why?
| | Elasticity | 1 | 2006 | 19 | 0.060 |
Why?
| | Inflammation | 1 | 2008 | 652 | 0.050 |
Why?
| | Female | 3 | 2017 | 28782 | 0.040 |
Why?
| | Equipment Design | 2 | 2011 | 290 | 0.040 |
Why?
| | Claudin-5 | 1 | 2018 | 2 | 0.030 |
Why?
| | Occludin | 1 | 2018 | 5 | 0.030 |
Why?
| | Tight Junction Proteins | 1 | 2018 | 7 | 0.030 |
Why?
| | Permeability | 1 | 2018 | 70 | 0.030 |
Why?
| | Biological Transport | 1 | 2018 | 150 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2018 | 1544 | 0.030 |
Why?
| | Thermodynamics | 1 | 2014 | 34 | 0.030 |
Why?
| | Titanium | 1 | 2014 | 36 | 0.030 |
Why?
| | Aniline Compounds | 1 | 2014 | 48 | 0.030 |
Why?
| | Surface Properties | 1 | 2011 | 61 | 0.020 |
Why?
| | Models, Anatomic | 1 | 2011 | 40 | 0.020 |
Why?
| | Elastic Modulus | 1 | 2010 | 12 | 0.020 |
Why?
| | Heart Valve Prosthesis | 1 | 2011 | 89 | 0.020 |
Why?
| | Computer Simulation | 1 | 2010 | 290 | 0.020 |
Why?
| | Aorta | 1 | 2009 | 172 | 0.020 |
Why?
| | Models, Structural | 1 | 2008 | 3 | 0.020 |
Why?
| | Diffusion Chambers, Culture | 1 | 2008 | 7 | 0.020 |
Why?
| | Hemorheology | 1 | 2008 | 6 | 0.020 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2008 | 17 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2008 | 43 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2009 | 260 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2008 | 315 | 0.020 |
Why?
| | Cytokines | 1 | 2008 | 627 | 0.010 |
Why?
|
|
Balachandran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|